Clinical and molecular significance of the RNA m6A methyltransferase complex in prostate cancer

ABSTRACT: shRNAs targeting METTL3 used to deplete METTL3 in castrate-resistant LNCaP:C42 prostate cancer cells and the effect on gene expression and splicing determined.

ORGANISM(S): Homo sapiens

PROVIDER: GSE210130 | GEO | 2023/01/04

REPOSITORIES: GEO